Business · Companies · 2 hrs ago
DL Chemical selects Glenwood PE as preferred bidder for Cariflex
DL Chemical has chosen Glenwood PE as the preferred bidder for Cariflex, its medical synthetic rubber business.
Cariflex is described as the world’s leading medical synthetic rubber company.
DL Chemical is part of South Korea’s DL Group and is a major petrochemicals affiliate.
The proposed sale is valued at the mid-to-high 1 trillion won range.
DL Chemical aims to reduce its borrowing and improve its finances through the deal.
The sale has been agreed, but the sources do not say it has been completed or give a timeline for what happens next.
DL Chemical selected Glenwood Private Equity as the preferred bidder for its Cariflex subsidiary.
The proposed sale is intended to ease DL Chemical’s debt burden and improve its financial structure.
Cariflex is described as the world’s leading medical synthetic-rubber company.
The reported deal value is in the mid-to-high 1 trillion won range.
- Who
- DL Chemical selected Glenwood Private Equity as the preferred bidder.
- What
- DL Chemical agreed to sell its Cariflex subsidiary.
- When
- November 4, 2026.
- Where
- Not stated.
- Why
- DL Chemical aims to reduce its borrowing burden and improve its financial structure.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Seller
- DL Chemical
- Preferred bidder
- Glenwood Private Equity
- Asset
- Cariflex
- Reported value
- Mid-to-high 1 trillion won range
- Cariflex description
- World’s leading medical synthetic-rubber company